OTC - ACTIVE INGREDIENT SECTION
glycerin
DR. IASO UV TOTAL BASE SPF 46 PA
- Manufacturer
- IASO Inc | Kolmar Korea Co., Ltd
- Effective date
- 2018-03-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:01:05
Label at a glance#
ProductDR. IASO UV TOTAL BASE SPF 46 PA
Active ingredientGLYCERIN
Label structure8 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
water, cyclopentasiloxane, ethylhexyl methoxycinnamate, titanium dioxide, zinc oxide, ethylhexyl salicylate, dipropylene glycol, peg-10 dimethicone, dicaprylyl carbonate, dimethicone, disteardimonium hectorite, magnesium sulfate, talc, aluminum hydroxide, bis-ethylhexyloxyphenol methoxyphenyl triazine, methyl methacrylate crosspolymer, portulaca oleracea ext, mica, phenoxyethanol, ci 77492, stearic acid, fragrance methicone, caprylyl glycol, dimethicone/vinyl dimethicone crosspolymer, ci 77491, ci 77499, aloe barbadensis leaf water, glyceryl caprylate, polyglyceryl-6 polyricinoleate, tocopheryl acetate, triethoxycaprylylsilane, honey ext, opuntia ficus-indica ext, sodium hyaluronate, aminopropyl dimethicone, polymethylsilsesquioxane, rosemary ext, jasmine ext, lavender, ext, algae ext, milk protein, raffinose, jojoba seed oil
OTC - PURPOSE SECTION
skin protectant
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
use after applying the basic care products. using fingertips smooth evenly over cheecks, forehead, nose and chin. blend must be removed with an appropriate makeup solvent.
WARNINGS SECTION
- Stop using if sensitivities occurs and consult with dermatologist
- sensitivities such as red marks, intumescence, urtication, irritation during use
-Have sensitivities as above on applied part by direct sun ray
- Do not store at high and low temperatures and avoid sunlight.
DOSAGE & ADMINISTRATION SECTION
for external use only
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75847-1708-1 | 2024-06-30 | C162847 | 48780-1 | d6a99b39-4ebd-a426-e053-dadaa90af4c2 | Drug Facts |
| 75847-1708-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-4ebd-a426-e053-dadaa90af4c2 | Drug Facts |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Products#
Every source-derived product name is available through these pages.
- DR. IASO UV TOTAL BASE SPF 46 PA
- GLYCERIN
- WATER
- ZINC OXIDE
- HYALURONATE SODIUM
- PHENOXYETHANOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 75847-1708 | 75847-1708-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1bcebfea-fefe-96cd-e063-6294a90a07f1 | b35802d8-448b-4da1-a959-446c878a8f68 | 2024-06-26 | Warnings | b35802d8-448b-4da1-a959-446c878a8f68 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.